EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pancreatic steatosis is not associated with impaired insulin secretion among individuals with diabetes

Aleksi Laitinen, Katarina Johansson, Aki J Käräjämäki, Annemari Käräjämäki, Jenny Häggblom, Liisa Hakaste, Samu Kurki, Kaj Lahti, Emma Ahlqvist, Tiinamaija Tuomi

The Journal of Clinical Endocrinology & Metabolism · 2026-10-16

DOI: 10.1210/clinem/dgag416 ↗
AbstractBibliografische Angaben

Abstract

Abstract Aims We aimed to assess pancreatic and hepatic steatosis (PS/HS) association with residual insulin secretion and insulin resistance in individuals with diabetes. Methods Pancreatic/liver fat fractions (PFF/LFF) in magnetic resonance imaging (MRI) were used as a proxy for PS and HS in 170 participants. Insulin secretion was estimated by HOMA2-B, C-peptide response 6 minutes after an intravenous bolus of 0.5 mg glucagon (ΔC-Pe), and fasting proinsulin to C-peptide ratio (PI:C). Insulin resistance was estimated by HOMA2-IR, Adipo-IR, and intravenous insulin (0.05 IU/kg) tolerance test. Results PFF did not correlate with measures of insulin secretion, but it correlated with fasting indices of insulin resistance among women (HOMA2-IR, R = 0.26, P = .017; Adipo-IR, R = 0.29, P = .007). Both LFF and PFF correlated with BMI (R = 0.43 and R = 0.34, respectively, P < .001) but not with each other (R = 0.10, P = .215). Unlike PS, HS was associated with higher HOMA2-IR, Adipo-IR, HOMA2-B, PI:C, and glucagon, after adjustment with confounders. Participants with PS without HS had lower fasting C-peptide, HOMA2-IR, HOMA2-B, Adipo-IR, glucagon, and triglycerides (P < .05) compared to those having HS without PS. Cluster-based subgroups of diabetes did not differ in PF (P = .071). Conclusion Within this cohort, pancreatic fat was more strongly associated with adiposity than with the investigated measures of β-cell function or insulin resistance.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →